dobutamine has been researched along with losartan potassium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegra, A; Aloisi, C; Buemi, M; Corica, F; Frisina, N; Galasso, A; Laganà , A; Siracusano, L | 1 |
Becker, T; Freudenthaler, S; Gleiter, CH; Gundert-Remy, U; Schreeb, KH | 1 |
1 trial(s) available for dobutamine and losartan potassium
Article | Year |
---|---|
Fenoterol but not dobutamine increases erythropoietin production in humans.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cyclic AMP; Dobutamine; Erythropoiesis; Erythropoietin; Fenoterol; Hematocrit; Hemoglobins; Humans; Kidney; Male; Phlebotomy; Renin; Single-Blind Method | 1997 |
1 other study(ies) available for dobutamine and losartan potassium
Article | Year |
---|---|
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock.
Topics: Dobutamine; Dopamine; Erythropoietin; Fatal Outcome; Female; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Artery; Recombinant Proteins; Shock; Vascular Resistance | 1996 |